Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9
about
Expression of complement components differs between kidney allografts from living and deceased donorsTherapeutic regulation of complement in patients with renal disease - where is the promise?Tubulointerstitial injury and the progression of chronic kidney diseaseDefining the CD59-C9 binding interactionComplement in glomerular injury.Review: Complement and its regulatory proteins in kidney diseases.Factor h and properdin recognize different epitopes on renal tubular epithelial heparan sulfate.Targeted mouse complement inhibitor CR2-Crry protects against the development of atherosclerosis in mice.C5b-9-targeted molecular MR imaging in rats with Heymann nephritis: a new approach in the evaluation of nephrotic syndrome.The critical role of complement alternative pathway regulator factor H in allergen-induced airway hyperresponsiveness and inflammation.Complement-mediated dysfunction of glomerular filtration barrier accelerates progressive renal injury.C5b-9 does not mediate tubulointerstitial injury in experimental acute glomerular disease characterized by selective proteinuria.C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathyNew therapeutic and diagnostic opportunities for injured tissue-specific targeting of complement inhibitors and imaging modalities.Novel targets for immunotherapy in glomerulonephritis.Dynamic control of the complement system by modulated expression of regulatory proteins.An update on the pathomechanisms and future therapies of Alport syndrome.The role of the immune system in idiopathic nephrotic syndrome: a review of clinical and experimental studies.Complement activation in progressive renal disease.Role of complement in glomerular diseases.Monomeric C-reactive protein inhibits renal cell-directed complement activation mediated by properdin.The bittersweet taste of tubulo-interstitial glycans.Complement activation by tubular cells is mediated by properdin binding.Soluble complement receptor type 1 inhibits complement system activation and improves motor function in acute spinal cord injury.Taurine Supplementation Alleviates Puromycin Aminonucleoside Damage by Modulating Endoplasmic Reticulum Stress and Mitochondrial-Related Apoptosis in Rat Kidney.Urinary properdin excretion is associated with intrarenal complement activation and poor renal function
P2860
Q24654702-F4AD7162-5A8F-4FF2-81F9-4657602D1021Q26851705-C35A5DC2-1D7A-4978-AB5A-ABC3974E931CQ26852862-BE5CAC94-E78E-43C6-9E08-E242A0D1A584Q28252317-5BBC421F-3147-44F4-BB90-9D63B994C97FQ33376840-57D2419C-D37C-402E-A8C8-29C0D79D3EE4Q33647738-8DFE99EB-BF90-44F3-9B54-628AA9115B2EQ34344501-D253E9B0-99E0-4A9B-8B94-984D18DC5736Q34712205-7918FEA5-D200-48E8-9053-2401A7A316DDQ35181694-6481A733-2F36-40DC-8B45-097F1EF541E5Q35659039-3832D90A-B81C-46B8-B38C-207C735C6130Q36677636-FC438B5D-8476-499C-A1C8-06002A757DA3Q36844814-1D12CDEC-CA4B-4C63-ACEF-3C3772DBBB5CQ37123256-8256043F-7A65-4CEC-A521-6B0F11DED173Q37180522-7C54CF85-BFA6-41A9-81F1-4516AD3354DFQ37290692-106E82A3-8ADD-409F-90C1-5BF954B2C0E6Q37797869-40E5B49C-233C-4A99-BAD0-FF952869BCA4Q38035773-962BCF9A-1997-432C-A663-A0DB52E0C1D9Q38152259-7AB2BB2D-0594-4CFE-BA02-5D5161811958Q38348940-EF201D6A-28FD-45F3-BCD8-052B31BCF4FEQ38591917-917152C5-85EA-4063-AC3C-0A551224D26CQ38785657-3AEBAAFB-5B1E-46E7-A0CA-DD3E9FA5112AQ39240506-28CBB6CE-1D6E-4953-87FC-48FFD0CBBD75Q39946407-87D2AEF5-F16B-4DCE-A1B4-1EBD405F978DQ51811448-E7C70F99-3171-4535-A071-B1C24FB07D79Q55449302-D5E7C446-1C06-4F2E-B551-41EA0D5EE8AFQ57790022-3D268133-2017-4BED-A25E-BF215EAD150D
P2860
Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9
description
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2005
@ast
im Mai 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2005/05/01)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/05/01)
@nl
наукова стаття, опублікована в травні 2005
@uk
مقالة علمية (نشرت في مايو 2005)
@ar
name
Complement inhibitors targeted ...... monstrate a key role for C5b-9
@ast
Complement inhibitors targeted ...... monstrate a key role for C5b-9
@en
Complement inhibitors targeted ...... monstrate a key role for C5b-9
@nl
type
label
Complement inhibitors targeted ...... monstrate a key role for C5b-9
@ast
Complement inhibitors targeted ...... monstrate a key role for C5b-9
@en
Complement inhibitors targeted ...... monstrate a key role for C5b-9
@nl
prefLabel
Complement inhibitors targeted ...... monstrate a key role for C5b-9
@ast
Complement inhibitors targeted ...... monstrate a key role for C5b-9
@en
Complement inhibitors targeted ...... monstrate a key role for C5b-9
@nl
P2093
P1476
Complement inhibitors targeted ...... monstrate a key role for C5b-9
@en
P2093
Hongbin Song
Masaki Imai
Richard J. Quigg
Stephen Tomlinson
P304
P356
10.4049/JIMMUNOL.174.9.5750
P407
P577
2005-05-01T00:00:00Z